Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Covington
Deloitte
Fish and Richardson
Cipla
Accenture
QuintilesIMS
Teva
AstraZeneca

Generated: December 12, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2004-174770

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpTAFINLARdabrafenib mesylateCAPSULE;ORAL202806-001May 29, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpTAFINLARdabrafenib mesylateCAPSULE;ORAL202806-002May 29, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-001May 29, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-001May 29, 2013RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-001May 29, 2013RXYesNo► Subscribe► Subscribe► SubscribeIN COMBINATION WITH DABRAFENIB FOR THE TREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA.
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-002May 29, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-002May 29, 2013DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-002May 29, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeIN COMBINATION WITH DABRAFENIB FOR THE TREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA.
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-003May 29, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpMEKINISTtrametinib dimethyl sulfoxideTABLET;ORAL204114-003May 29, 2013RXYesYes► Subscribe► Subscribe► SubscribeIN COMBINATION WITH DABRAFENIB FOR THE TREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA.
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist